about
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humansAssessment of global cardiac uptake of radiolabeled iron oxide nanoparticles in apolipoprotein-E-deficient mice: implications for imaging cardiovascular inflammation.Body-wide hierarchical fuzzy modeling, recognition, and delineation of anatomy in medical images.Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot studyIncreased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans.Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysisA phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.A new dimension of FDG-PET interpretation: assessment of tumor biology.Role of FDG PET/CT in investigating the mechanisms underlying atherosclerotic plaque formation and evolution.Detection and Quantification of Molecular Calcification by PET/Computed Tomography: A New Paradigm in Assessing Atherosclerosis.Prognostic Predictors of Visual Outcome in Open Globe Injury: Emphasis on Facial CT Findings.Computer-Aided Reporting of Chest Radiographs: Efficient and Effective Screening in the Value-Based Imaging Era.Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain".Role of Global Disease Assessment by Combined PET-CT-MR Imaging in Examining Cardiovascular Disease.Quantification of aging effects upon global knee inflammation by 18F-FDG-PET.Erectile dysfunction severity as a risk predictor for coronary artery disease.Reinventing Radiology: Big Data and the Future of Medical Imaging.Feature analysis of ultrasound elastography image for quantitative assessment of cutaneous carcinoma.Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.Finding the sweet spot for metformin in 18F-FDG-PET.FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.Quantitative normal thoracic anatomy at CT.A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT".Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study.Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT: a pilot study.Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation.Imaging the infected heart.Suboptimal and inadequate quantification: an alarming crisis in medical applications of PETEvolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disordersPromising Roles of PET in Management of Arthroplasty-Associated Infection
P50
Q29614348-B87FB067-8A5F-4BB6-83F2-3E96CF704C77Q33590975-5BB80222-C424-423D-A25E-3F43A7195FBBQ33863862-77F51037-E683-46E4-929E-8AAA9D62F57DQ34054198-82A2C760-539E-46E7-B810-EDA754E43B2CQ35171276-402F0D4E-1B1B-4289-B494-B06609F7CA01Q36225333-FB53CFA9-5AB4-4678-8EE9-3D87DB17E7C1Q36305268-B47B5636-8850-41EF-8C45-BC6CB8A0A90BQ36557458-799839D3-9648-448C-B5C3-647D5E64B973Q37325331-5CCF8899-EC64-4633-932C-47D3588826B5Q37821378-3924A908-9425-4709-BB15-CFA1271E39F1Q37827751-9EE887BC-2142-4720-9E44-7D1970B9310DQ37827752-6115EFDC-93CD-4021-B242-560284E5646EQ38111047-44D59851-196E-4B43-84D4-564F1AACE03CQ38828819-3E3A018B-73D8-4B4D-B1F8-8500A5955203Q38902545-0D4CB035-D9F4-41BE-B09F-32919E9566E9Q38982704-DCCCE85D-DAA1-4ACD-A07D-E9B1C189DA0AQ39404791-DC51B4BF-D400-48A4-9C2D-352BEDAA5AC6Q39703182-2A45F13B-CF2B-4201-9B8C-40E4FE84E98CQ40337167-AB73B48D-6E90-453C-8E31-AE16D555E101Q43268632-2DD08C60-1292-495A-B963-6032AEA5A61FQ47291040-141CDACB-A7BD-479C-BBBB-7ED70C28763EQ48132208-CBE5763A-3CAE-43A5-9C77-58D17E017BDDQ48841044-3390DC94-E6A6-4009-A0EE-CAB77BE487ABQ50505396-E070EEED-6D45-43AD-A0FB-408852F296BCQ51139977-57A5120D-1AA7-4F22-BA3B-9D3F4B8FE79CQ52983720-899F57E0-CAE7-4408-9966-A55E8FBCBA68Q53025054-A948B56F-D396-4E31-A3C6-1743FF940BE6Q53086137-8D4F8303-0D00-48FD-AC8D-2E32E433864EQ53088229-1EE9F72F-FD16-4EA4-9757-073A1E7A5EC7Q53090438-9EF7AC82-1FE0-444A-B89F-4ABD0D3530B7Q53104200-5C3D0FE7-2B11-4BCB-8FC5-2E71F3C61683Q53203743-3814D8BA-E4C6-4B91-B686-29FC334E6E93Q83672912-F695823F-6978-4AE8-A780-1A1418380814Q83752916-9FBA5B96-61DD-495A-9523-9460CD0ABD49Q89392466-FD064EC5-8CE6-41FF-B033-11D1610D651C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Babak Saboury
@ast
Babak Saboury
@en
Babak Saboury
@es
Babak Saboury
@nl
Babak Saboury
@sl
type
label
Babak Saboury
@ast
Babak Saboury
@en
Babak Saboury
@es
Babak Saboury
@nl
Babak Saboury
@sl
prefLabel
Babak Saboury
@ast
Babak Saboury
@en
Babak Saboury
@es
Babak Saboury
@nl
Babak Saboury
@sl
P106
P1153
36057036200
P2456
P31
P496
0000-0002-8632-6292